Establishment and Characterisation of Heterotopic Patient-Derived Xenografts for Glioblastoma
Cancers - Switzerland
doi 10.3390/cancers12040871
Full Text
Open PDFAbstract
Available in full text
Date
April 3, 2020
Authors
Publisher
MDPI AG
Available in full text
April 3, 2020
MDPI AG